These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24739980)

  • 1. Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors.
    Nébié I; Edwards NJ; Tiono AB; Ewer KJ; Sanou GS; Soulama I; Sanon S; Diarra A; Yaro JB; Kangoye D; Imoukhuede EB; Hill AV; Sirima SB
    Clin Vaccine Immunol; 2014 Jun; 21(6):901-3. PubMed ID: 24739980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
    Dudareva M; Andrews L; Gilbert SC; Bejon P; Marsh K; Mwacharo J; Kai O; Nicosia A; Hill AV
    Vaccine; 2009 Jun; 27(27):3501-4. PubMed ID: 19464527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
    O'Hara GA; Duncan CJ; Ewer KJ; Collins KA; Elias SC; Halstead FD; Goodman AL; Edwards NJ; Reyes-Sandoval A; Bird P; Rowland R; Sheehy SH; Poulton ID; Hutchings C; Todryk S; Andrews L; Folgori A; Berrie E; Moyle S; Nicosia A; Colloca S; Cortese R; Siani L; Lawrie AM; Gilbert SC; Hill AV
    J Infect Dis; 2012 Mar; 205(5):772-81. PubMed ID: 22275401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.
    Paris R; Kuschner RA; Binn L; Thomas SJ; Colloca S; Nicosia A; Cortese R; Bailer RT; Sullivan N; Koup RA
    Clin Vaccine Immunol; 2014 May; 21(5):783-6. PubMed ID: 24623627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
    Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
    Front Immunol; 2018; 9():335. PubMed ID: 29563911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys.
    Ersching J; Hernandez MI; Cezarotto FS; Ferreira JD; Martins AB; Switzer WM; Xiang Z; Ertl HC; Zanetti CR; Pinto AR
    Virology; 2010 Nov; 407(1):1-6. PubMed ID: 20797754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
    Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
    PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
    Mensah VA; Gueye A; Ndiaye M; Edwards NJ; Wright D; Anagnostou NA; Syll M; Ndaw A; Abiola A; Bliss C; Gomis JF; Petersen I; Ogwang C; Dieye T; Viebig NK; Lawrie AM; Roberts R; Nicosia A; Faye B; Gaye O; Leroy O; Imoukhuede EB; Ewer KJ; Bejon P; Hill AV; Cisse B;
    PLoS One; 2016; 11(12):e0167951. PubMed ID: 27978537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel vaccine vectors: Chimpanzee adenoviral vectors.
    Guo J; Mondal M; Zhou D
    Hum Vaccin Immunother; 2018 Jul; 14(7):1679-1685. PubMed ID: 29300685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults.
    Ogwang C; Kimani D; Edwards NJ; Roberts R; Mwacharo J; Bowyer G; Bliss C; Hodgson SH; Njuguna P; Viebig NK; Nicosia A; Gitau E; Douglas S; Illingworth J; Marsh K; Lawrie A; Imoukhuede EB; Ewer K; Urban BC; Hill AVS; Bejon P;
    Sci Transl Med; 2015 May; 7(286):286re5. PubMed ID: 25947165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.
    Longley RJ; Halbroth BR; Salman AM; Ewer KJ; Hodgson SH; Janse CJ; Khan SM; Hill AVS; Spencer AJ
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28031267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.
    Xiang Z; Li Y; Cun A; Yang W; Ellenberg S; Switzer WM; Kalish ML; Ertl HC
    Emerg Infect Dis; 2006 Oct; 12(10):1596-9. PubMed ID: 17176582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
    Cheng T; Wang X; Song Y; Tang X; Zhang C; Zhang H; Jin X; Zhou D
    Vaccine; 2016 Sep; 34(41):4875-4883. PubMed ID: 27576071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.
    de Barra E; Hodgson SH; Ewer KJ; Bliss CM; Hennigan K; Collins A; Berrie E; Lawrie AM; Gilbert SC; Nicosia A; McConkey SJ; Hill AV
    PLoS One; 2014; 9(12):e115161. PubMed ID: 25522180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.
    Tiono AB; Nébié I; Anagnostou N; Coulibaly AS; Bowyer G; Lam E; Bougouma EC; Ouedraogo A; Yaro JBB; Barry A; Roberts R; Rampling T; Bliss C; Hodgson S; Lawrie A; Ouedraogo A; Imoukhuede EB; Ewer KJ; Viebig NK; Diarra A; Leroy O; Bejon P; Hill AVS; Sirima SB
    PLoS One; 2018; 13(12):e0208328. PubMed ID: 30540808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
    Rampling T; Ewer KJ; Bowyer G; Bliss CM; Edwards NJ; Wright D; Payne RO; Venkatraman N; de Barra E; Snudden CM; Poulton ID; de Graaf H; Sukhtankar P; Roberts R; Ivinson K; Weltzin R; Rajkumar BY; Wille-Reece U; Lee CK; Ockenhouse CF; Sinden RE; Gerry S; Lawrie AM; Vekemans J; Morelle D; Lievens M; Ballou RW; Cooke GS; Faust SN; Gilbert S; Hill AV
    J Infect Dis; 2016 Sep; 214(5):772-81. PubMed ID: 27307573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.
    Limbach K; Stefaniak M; Chen P; Patterson NB; Liao G; Weng S; Krepkiy S; Ekberg G; Torano H; Ettyreddy D; Gowda K; Sonawane S; Belmonte A; Abot E; Sedegah M; Hollingdale MR; Moormann A; Vulule J; Villasante E; Richie TL; Brough DE; Bruder JT
    Malar J; 2017 Jul; 16(1):263. PubMed ID: 28673287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components.
    Fedosyuk S; Merritt T; Peralta-Alvarez MP; Morris SJ; Lam A; Laroudie N; Kangokar A; Wright D; Warimwe GM; Angell-Manning P; Ritchie AJ; Gilbert SC; Xenopoulos A; Boumlic A; Douglas AD
    Vaccine; 2019 Nov; 37(47):6951-6961. PubMed ID: 31047679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimpanzee Adenovirus Vector Ebola Vaccine.
    Ledgerwood JE; DeZure AD; Stanley DA; Coates EE; Novik L; Enama ME; Berkowitz NM; Hu Z; Joshi G; Ploquin A; Sitar S; Gordon IJ; Plummer SA; Holman LA; Hendel CS; Yamshchikov G; Roman F; Nicosia A; Colloca S; Cortese R; Bailer RT; Schwartz RM; Roederer M; Mascola JR; Koup RA; Sullivan NJ; Graham BS;
    N Engl J Med; 2017 Mar; 376(10):928-938. PubMed ID: 25426834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.